Trial Profile

A Double-blind, Randomized, Placebo-controlled Study of the Safety and Efficacy of SYN 115 as Adjunctive Therapy in Levodopa-treated Parkinson's Subjects With End of Dose Wearing Off

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 23 Jan 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

08 Jun 2017 Results of a post-hoc analysis from this trial presented at the 21st International Congress of Parkinson's Disease and Movement Disorders
19 Jan 2016 Results published in an Acorda Therapeutics media release.
20 Feb 2015 According to Biotie Therapies media release, it expects that the Phase 2b study will be considered the first of two pivotal studies required for registration for tozadenant in PD patients with end-of-dose 'wearing-off'.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com